Genomic biomarkers correlate with HLA-identical renal transplant tolerance

Journal of the American Society of Nephrology

Volumn 24, Issue 9, 2013, Pages 1376-1385

  Leventhal, Joseph R ^a   Mathew, James M ^a   Salomon, Daniel R ^b   Kurian, Sunil M ^b   Suthanthiran, Manikkam ^c   Tambur, Anat ^a   Friedewald, John ^a   Gallon, Lorenzo ^a   Charette, Jane ^a   Levitsky, Josh ^a   Kanwar, Yashpal ^a   Abecassis, Michael ^a   Miller, Joshua ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD103 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CREATININE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; HLA ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RNA 18S; TACROLIMUS; TOLL LIKE RECEPTOR 5; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; CD34 SELECTION; CD4+ CD25+ T LYMPHOCYTE; CHIMERA; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; GENOMICS; HEMATOPOIETIC STEM CELL; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; MICROARRAY ANALYSIS; NEPHROSCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; SIBLING; TREATMENT OUTCOME; URINE;

EID: 84884346302     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013010068     Document Type: Article

References (25)

1. Kawai T,Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DSC, Hertl M, Goes NB, Wong W, Williams WW Jr, Colvin RB, Sykes M, Sachs DH: HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358: 353-361, 2008
2. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S: Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 358: 362-368, 2008
3. Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud DJ, King B, Elliott MJ, Herzig G, Herzig R, Ildstad ST: Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 4: 124ra128, 2012
4. Dave SD, Vanikar A, Trivedi HL, Gumber MR, Patel HV, Shah PR, Kute VB. Stemcells versus donor specific transfusions for tolerance induction in living donor renal transplantation: A single-center experience.. Transplantation 95: 155-160, 2013
5. Miller J, Leventhal J, Friedewald J, Levitsky J, Charette J, Huang X, Gopalakrishnan MT, Chandrasekaran D, Tambur AR, Mathew JM: Enhanced immunoregulatory profiles in HLA identical renal transplant recipientsgiven donor hematopoetic stem cells alemtuzumab and sirolimus followed by immunosuppression withdrawal [Abstract]. AmJ Transplant 11: 92, 2011
6. Miller J, Leventhal J, Abecassis M, Chen L, Chandrasekaran D, Huang X, Levitsky J, Tambur A, Friedewald J, Mathew J: Prospectively induced immune tolerance vs. spontaneous operational tolerance in nonchimeric HLA identical renal transplants [Abstract]. Am J Transplant 12: 563, 2012
7. Heidt S, Hester J, Shankar S, Friend PJ, Wood KJ: B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells. Am J Transplant 12: 1784-1792, 2012
8. Seigler HF, Gunnells JC Jr, Robinson RR, Ward FE, Amos DB, Rowlands DT, Burkholder PM, Klein WJ, Stickel DL: Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. J Clin Invest 51: 3200-3215, 1972
9. Gerrits JH, van deWetering J,Weimar W, van Besouw NM: T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical livingrelated renal transplant recipients. Transplantation 87: 907-914, 2009
10. van de Wetering J, Gerrits JH, van Besouw NM, Ijzermans JNM, Weimar W: Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation. Transplantation 87: 740-744, 2009
11. Brouard S,Mansfield E, Braud C, Li L,GiralM, Hsieh SC, Baeten D, ZhangM, Ashton-Chess J, Braudeau C, Hsieh F, Dupont A, Pallier A, Moreau A, Louis S, Ruiz C, Salvatierra O, Soulillou J-P, Sarwal M: Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 104: 15448-15453, 2007
12. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Turka LA, Seyfert-Margolis VL; Immune Tolerance Network ST507 Study Group: Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120: 1836-1847, 2010
13. LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman SL, Spitzer TR, Tolkoff-RubinN, Cosimi AB, SachsDH, Sykes M: Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation 90: 1607-1615, 2010
14. Leventhal J, Abecassis M, Miller J, Gallon L, TollerudD, ElliottMJ, Bozulic LD,HoustonC, Sustento-Reodica N, Ildstad ST: Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: Durable chimerismpredicts outcome. Transplantation, 95: 169-176, 2013
15. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Sarwal M, Millan MT, Shizuru JA, Lowsky R, Engleman EG, Strober S: Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 12: 1133-1145, 2012
16. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB: Combined histocompatibility leukocyte antigenmatched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68: 480-484, 1999
17. Benacerraf B: Role of major histocompatibility complex in genetic regulation of immunologic responsiveness. Transplant Proc 9: 825-831, 1977
18. Guo Z, Hood L, Malkki M, Petersdorf EW: Long-range multilocus haplotype phasing of the MHC. Proc Natl Acad Sci U S A 103: 6964-6969, 2006
19. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164, 1995
20. Bouaziz J-D, Yanaba K, Tedder TF: Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 224: 201-214, 2008
21. Iwata Y,Matsushita T, HorikawaM, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD, Hall RP, St Clair EW, Tedder TF: Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117: 530-541, 2011
22. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M: Messenger RNA for FOXP3 in the urine of renalallograft recipients. N Engl J Med 353: 2342-2351, 2005
23. Afaneh C, Muthukumar T, Lubetzky M, Ding R, Snopkowski C, Sharma VK, Seshan S, Dadhania D, Schwartz JE, Suthanthiran M: Urinary cell levels ofmRNA forOX40,OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation 90: 1381-1387, 2010
24. Naji A, Silvers WK, Bellgrau D, Barker CF: Spontaneous diabetes in rats: Destruction of islets is prevented by immunological tolerance. Science 213: 1390-1392, 1981
25. Bray RA, Lebeck LK, Gebel HM: The flow cytometric crossmatch.Dual-color analysis of T cell and B cell reactivities. Transplantation 48: 834-840, 1989